AuthorCitation

Weekly paclitaxel and carboplatin may be an option for salvage chemotherapy in stage IV melanoma patients

Rao, R. D., Creagan, Edward T. , Pitot, H. C., Markovic, S. N. , Holtan, Shernan G. , Kaur, Jasbir

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7572-7572

10.1200/jco.2005.23.16_suppl.7572

High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial

Richards, Jon, Bedikian, A. Y., González, René , Whitman, Eric D. , Morse, Mark A. , Amatruda, Thomas, Galanis, E., Thompson, Joyce, Atkins, Michael B. , Lutzky, Jose

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7543-7543

10.1200/jco.2005.23.16_suppl.7543

Phase II trial of oral vinorelbine for treatment of metastatic breast cancer in women 65 years and older: N003A

Baweja, Mansoina, Fitch, Tom R., Mailliard, J A, Bernath, Albert M., Rowland, Kendrith M. , Kaur, Judith S. , Perez, Edith A. , Suman, Vera J. , Alberts, Steven R.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 740-740

10.1200/jco.2005.23.16_suppl.740

A pooled analysis of 11 NCCTG advanced stage non-small cell lung cancer (NSCLC) trials reveals the importance of baseline blood counts on clinical outcomes

Mandrekar, Sumithra J. , Hillman, Shauna L., Foster, Nathan R. , Adjei, Alex A. , Marks, Randolph S., Mailliard, J A, Krook, James E., Maksymiuk, Andrew W., Jett, James R., Schild, Steven E.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7193-7193

10.1200/jco.2005.23.16_suppl.7193

A phase I/II NCCTG trial of escalating doses of twice daily thoracic radiation therapy (TRT) in limited-stage small cell lung cancer (LSCLC)

Garces, Yolanda I. , Okuno, Scott H. , Mandrekar, Sumithra J. , Mailliard, J A, Kahanic, Stephen P., Rao, Roshni , Moore, Dennis F., Kozelsky, Timothy F., Jett, James R., Schild, Steven E.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7163-7163

10.1200/jco.2005.23.16_suppl.7163

A phase III randomized placebo controlled NCCTG trial of carboxyaminoimidazole (CAI) in patients with advanced non-small cell lung cancer (NSCLC)

Marks, Randolph S., Mandrekar, Sumithra J. , Hillman, Shauna L., Mailliard, J A, Dentchev, Todor, Reuter, Nicholas F., Jett, James R., Perez, Edith A. , Johnson, Elizabeth Anne

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7054-7054

10.1200/jco.2005.23.16_suppl.7054

Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309)

Albain, Kathy S. , Turrisi, Andrew T., Smith, Colum J , Johnson, David H. , Green, M. R., Miller, R., Swann, Ruth , Rusch, Valerie W. , Shepherd, Frances Alice , Gandara, David R.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 7014-7014

10.1200/jco.2005.23.16_suppl.7014

Thalidomide and dexamethasone in newly diagnosed multiple myeloma: Long-term results in patients not undergoing upfront autologous stem cell transplantation

Nowakowski, Grzegorz S. , Lacy, Martha Q. , Hayman, S. R., Zeldenrust, Stephen R., Lust, John A., Greipp, Philip R., Kyle, Robert A. , Rajkumar, S. Vincent , Dingli, David , Gertz, Morie A. , Dispenzieri, Angela , Fonseca, Rafaël , Witzig, Thomas E.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6632-6632

10.1200/jco.2005.23.16_suppl.6632

Yttrium 90 ibritumomab tiuxetan is safe and effective in older patients with relapsed or refractory NHL

Schilder, Russell J., Emmanouilides, C., Vo, Katie D. , Darif, Mohamed, Witzig, Thomas E. , Flinn, Ian W. , Gordon, Leo I. , Molina, Aurelia Alañón

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6562-6562

10.1200/jco.2005.23.16_suppl.6562

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

Behl, Deepti , Porrata, Luis F. , Elliott, Michelle A. , Hook, C. Christopher , Letendre, Louis, Pruthi, Rajiv K. , Tefferi, Ayalew , Litzow, Mark R. , Markovic, Svetomir N. , Kaufmann, Scott H.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6553-6553

10.1200/jco.2005.23.16_suppl.6553

Citations

Weekly paclitaxel and carboplatin may be an option for salvage chemotherapy in stage IV melanoma patients

Rao, R. D., Creagan, Edward T. , Pitot, H. C., Markovic, S. N. , Holtan, Shernan G. , Kaur, Jasbir

High-dose Allovectin-7 in patients with advanced metastatic melanoma: final phase 2 data and design of phase 3 registration trial

Richards, Jon, Bedikian, A. Y., González, René , Whitman, Eric D. , Morse, Mark A. , Amatruda, Thomas, Galanis, E., Thompson, Joyce, Atkins, Michael B. , Lutzky, Jose

Phase II trial of oral vinorelbine for treatment of metastatic breast cancer in women 65 years and older: N003A

Baweja, Mansoina, Fitch, Tom R., Mailliard, J A, Bernath, Albert M., Rowland, Kendrith M. , Kaur, Judith S. , Perez, Edith A. , Suman, Vera J. , Alberts, Steven R.

A pooled analysis of 11 NCCTG advanced stage non-small cell lung cancer (NSCLC) trials reveals the importance of baseline blood counts on clinical outcomes

Mandrekar, Sumithra J. , Hillman, Shauna L., Foster, Nathan R. , Adjei, Alex A. , Marks, Randolph S., Mailliard, J A, Krook, James E., Maksymiuk, Andrew W., Jett, James R., Schild, Steven E.

A phase I/II NCCTG trial of escalating doses of twice daily thoracic radiation therapy (TRT) in limited-stage small cell lung cancer (LSCLC)

Garces, Yolanda I. , Okuno, Scott H. , Mandrekar, Sumithra J. , Mailliard, J A, Kahanic, Stephen P., Rao, Roshni , Moore, Dennis F., Kozelsky, Timothy F., Jett, James R., Schild, Steven E.

A phase III randomized placebo controlled NCCTG trial of carboxyaminoimidazole (CAI) in patients with advanced non-small cell lung cancer (NSCLC)

Marks, Randolph S., Mandrekar, Sumithra J. , Hillman, Shauna L., Mailliard, J A, Dentchev, Todor, Reuter, Nicholas F., Jett, James R., Perez, Edith A. , Johnson, Elizabeth Anne

Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): Outcomes update of North American Intergroup 0139 (RTOG 9309)

Albain, Kathy S. , Turrisi, Andrew T., Smith, Colum J , Johnson, David H. , Green, M. R., Miller, R., Swann, Ruth , Rusch, Valerie W. , Shepherd, Frances Alice , Gandara, David R.

Thalidomide and dexamethasone in newly diagnosed multiple myeloma: Long-term results in patients not undergoing upfront autologous stem cell transplantation

Nowakowski, Grzegorz S. , Lacy, Martha Q. , Hayman, S. R., Zeldenrust, Stephen R., Lust, John A., Greipp, Philip R., Kyle, Robert A. , Rajkumar, S. Vincent , Dingli, David , Gertz, Morie A. , Dispenzieri, Angela , Fonseca, Rafaël , Witzig, Thomas E.

Yttrium 90 ibritumomab tiuxetan is safe and effective in older patients with relapsed or refractory NHL

Schilder, Russell J., Emmanouilides, C., Vo, Katie D. , Darif, Mohamed, Witzig, Thomas E. , Flinn, Ian W. , Gordon, Leo I. , Molina, Aurelia Alañón

Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia

Behl, Deepti , Porrata, Luis F. , Elliott, Michelle A. , Hook, C. Christopher , Letendre, Louis, Pruthi, Rajiv K. , Tefferi, Ayalew , Litzow, Mark R. , Markovic, Svetomir N. , Kaufmann, Scott H.